Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer - Test2 - elhamkhani - TriplyDB

Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer

Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer

http://www.wikidata.org/entity/Q35034550

about

Vapor of volatile oils from Litsea cubeba seed induces apoptosis and causes cell cycle arrest in lung cancer cells The PI3K/Akt Pathway in Tumors of Endocrine Tissues Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms Maximising the potential of AKT inhibitors as anti-cancer treatments The critical role of Akt in cardiovascular function Essential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicity KCTD20, a relative of BTBD10, is a positive regulator of Akt Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling.Glycogen synthase kinase 3 protein kinase activity is frequently elevated in human non-small cell lung carcinoma and supports tumour cell proliferation.Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer Bariatric surgery in morbidly obese insulin resistant humans normalises insulin signalling but not insulin-stimulated glucose disposal.Diverse involvement of isoforms and gene aberrations of Akt in human lung carcinomas.Non-canonical Activation of Akt in Serum-Stimulated Fibroblasts, Revealed by Comparative Modeling of Pathway Dynamics RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3.A bead-based western for high-throughput cellular signal transduction analyses.Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2.Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells.Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase.Site-specific activation of AKT protects cells from death induced by glucose deprivation.Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma The Paradox of Akt-mTOR Interactions.Signalling specificity in the Akt pathway in breast cancer.Impact of resistance exercise on ribosome biogenesis is acutely regulated by post-exercise recovery strategies.ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing.mTOR in health and in sickness.Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells.A comparative survey of functional footprints of EGFR pathway mutations in human cancers.Parkinson's disease-associated DJ-1 mutations increase abnormal phosphorylation of tau protein through Akt/GSK-3β pathways.Rac-1 superactivation triggers insulin-independent glucose transporter 4 (GLUT4) translocation that bypasses signaling defects exerted by c-Jun N-terminal kinase (JNK)- and ceramide-induced insulin resistance.Antibiotic drug tigecycline reduces neuroblastoma cells proliferation by inhibiting Akt activation in vitro and in vivo.

P2860

Q21090858-16502558-12BA-4545-93EF-3FF09F1FD21D Q26770404-9AC6BFBE-37F5-4C01-A9B7-AEC1FA3D1D46 Q26798203-179B1FB3-7A54-45D1-9DC7-59C3EC4639C0 Q26862544-7F285B7D-2A6C-404B-9D79-3FE999642B60 Q28072254-5495AB67-5FCB-4A09-A54E-D01AD950F933 Q28083829-F64BCBC6-1262-445F-BA5F-104623A8F1A4 Q28236954-233ED90D-6D43-4D0D-B05A-FA37C790FE8D Q28590940-0B40B33C-1219-4F34-AA88-49C5451D9CA0 Q33574190-2978484A-973F-4EB9-9D19-9E39E3C70F71 Q33755044-47427932-A2C3-4DFB-A1E2-DC3DAEC3B615 Q34092837-5DB82F76-4089-4D6F-8278-557BC4BEB048 Q34654039-3F602E6E-3B20-4AAF-9B73-25B3E0081A62 Q34796287-D25C826C-B068-4CBC-979D-1DF13848BDCE Q35256618-8B0BB200-84F9-440F-94E6-CEC0BD4955E7 Q35393067-119D0936-62AD-46CD-B27E-CFECAE56D26C Q35754270-037D46C1-6F35-4A85-B250-6BB09A9D5E28 Q35836933-72DB2CBD-0EDE-4408-B345-700DDACFF191 Q35925830-07C2CE26-488D-4B43-93A9-6102DF42C6B2 Q36141854-58D96784-7993-42BD-A81B-EDAD7B7169C1 Q36299173-1376E5FA-4412-4FF4-88BC-A19F7A91CF52 Q36340315-625E2411-1131-4F42-92F0-6E178C551F95 Q36688994-5F51746F-A530-498D-9158-D8C426E5F9FA Q36760689-8B79622B-CA70-4914-9DE8-65861D91A5FC Q37156395-B1F36E3B-062C-474E-A0C8-5DE7F8D3C358 Q37178573-1A8025E1-D435-44AC-902A-D635B4425D3C Q37233198-3FA6B0B9-D05B-4DFC-9A24-16CBC27E88E8 Q37417611-B9A48E72-079F-49B1-835A-20476996EE57 Q37520595-DBD2C167-A5E6-417C-8C0D-D9DFC1E5CB11 Q38117148-960EF8E4-E57C-408A-B2CA-3D5E0DCEAD26 Q38252278-96B3602F-456E-4D8B-B474-D804380B569F Q38564905-0E8686A5-C67B-4348-BC27-C29949E4AD2B Q38583728-983A8F41-A420-405F-B1B0-FA7E14DCCCEC Q38590634-90E3A799-BBB4-44F8-B1DB-130D7E88A025 Q38755819-CF01381C-23DE-4764-99AE-81A1DABC52D0 Q38959812-9358F727-24BB-4D55-B5D8-70DAFAF6CCB7 Q39013961-6BA181AB-F762-4272-964E-F0644BCF0E5D Q39069318-8E702871-5E37-411E-88D3-4513DF8075FD Q39104616-B8F141F0-5718-4089-AF27-541723BE9CC7 Q39156707-04F852E6-FCD8-4E28-A74D-962447EC793B Q40188774-63B95E5B-B666-4B51-9D5D-436BDB74110A

P2860

Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer

http://www.wikidata.org/entity/Q35034550

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Akt phosphorylation on Thr308 ...... man non-small cell lung cancer

@ast

Akt phosphorylation on Thr308 ...... man non-small cell lung cancer

@en

type

label

Akt phosphorylation on Thr308 ...... man non-small cell lung cancer

@ast

Akt phosphorylation on Thr308 ...... man non-small cell lung cancer

@en

prefLabel

Akt phosphorylation on Thr308 ...... man non-small cell lung cancer

@ast

Akt phosphorylation on Thr308 ...... man non-small cell lung cancer

@en

P1433

Q35034550-0D6DA813-9BC6-4D8D-B744-D04B42EB664D

P1476

Q35034550-A0D0DFB0-7512-4AD4-9F0E-BBD67199EE90

P2093

Q35034550-5530930E-7A63-411A-9768-FA18CA71BDC2

Q35034550-79441A78-DE60-474A-9184-8961D93FB632

Q35034550-7C214AB3-01D8-42A3-8EC1-647553A07E5A

Q35034550-A1FD9083-2C95-49A5-868C-1423F619D178

Q35034550-B4B5FFCA-A4E0-44B5-A5D3-6052CCA422EB

Q35034550-CCADF3D4-1B65-45FD-A1D4-2CA43F87A2F3

Q35034550-E899DA97-D986-41C0-835B-72A11645B4B4

Q35034550-ECC66E63-0BD9-4CAA-B89C-B9198B145D1E

P2860

Q35034550-0288A970-95D6-40DF-905F-3F825F18D807

Q35034550-0CAC3D44-EA3F-4CDC-8432-29A92E74D36D

Q35034550-141A679B-AC62-4E0A-9686-1D6CAE643326

Q35034550-1A8D8DFF-B8EA-487C-82C5-D7DD8F5E53EF

Q35034550-23750824-1A6C-49D8-87F8-1503AEB659B4

Q35034550-2FDD1F68-CF53-494B-BC9B-117271DACB66

Q35034550-39442C51-6DB7-4FAB-81C9-C17773147E67

Q35034550-3DACEAB3-5146-4494-80FA-3C9D699E5827

Q35034550-3F1A975D-AA34-4F6B-A82A-A254F16F7B23

Q35034550-6D1B713E-2324-4DA5-AF8D-457B0D0237DE

P2888

Q35034550-4007CEF8-B411-44EF-9970-DC396C5C8463

P304

Q35034550-D40F6541-6310-4095-A21A-6FE992123247

P31

Q35034550-6166C0DF-0EA1-4158-B121-798D44D55431

P356

Q35034550-95B060DF-7685-4A2D-BE11-7315CED08B9C

P407

Q35034550-C15A90C8-5549-4B97-8BD0-F162A10753FC

P433

Q35034550-733519B9-1B11-47CD-AD67-27A749A634ED

P478

Q35034550-5968E002-09C2-4E74-A3AF-A6C9864DD662

P50

Q35034550-068E4BD3-BF6C-4916-A629-372517F186FD

Q35034550-DECB65D3-DD31-47A3-AB2A-7B2D4A063E52

P577

Q35034550-F347417A-736C-4B43-BD39-59BC2F28773F

P5875

Q35034550-4C4D097E-71B8-4F16-BC49-82E56C085F68

P698

Q35034550-F45119D5-15F2-4098-87B6-0D16B5C83F9E

P921

Q35034550-9CFD6325-48FC-4BC6-8CC5-06B454B0E791

P932

Q35034550-F33BFC4A-06EE-4C94-B4F0-E42DD2C998E0

P356

P1433

British Journal of Cancer

P1476

Akt phosphorylation on Thr308 ...... man non-small cell lung cancer

@en

P2093

C Morgan

http://www.w3.org/2001/XMLSchema#string

D J E Elder

http://www.w3.org/2001/XMLSchema#string

E C Thomas

http://www.w3.org/2001/XMLSchema#string

J M Tavaré

http://www.w3.org/2001/XMLSchema#string

J Pawade

http://www.w3.org/2001/XMLSchema#string

L Phillips

http://www.w3.org/2001/XMLSchema#string

M R Hetzel

http://www.w3.org/2001/XMLSchema#string

M Sohail

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain

Mechanism of activation of protein kinase B by insulin and IGF-1

Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning

The PI3K-PDK1 connection: more than just a road to PKB

Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway

AKT/PKB signaling: navigating downstream

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway

Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

P2888

P304

1755-1761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2011.132

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Emma E. Vincent

P577

2011-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51063076

http://www.w3.org/2001/XMLSchema#string

P698

21505451

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

3111153

http://www.w3.org/2001/XMLSchema#string